Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry, Revision: v3.6.4, was added to the history. The previous Revision: v3.6.3 entry was removed.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page history revision label advanced from v3.6.2 to v3.6.3, indicating a new version of the page has been released.SummaryDifference0.0%

- Check43 days agoChange DetectedA new revision entry, Revision: v3.6.2, has been added to the Study Record History, replacing Revision: v3.6.0. This indicates a minor platform update to the history view.SummaryDifference0.0%

- Check57 days agoChange DetectedThe study page now shows that recruitment has ceased. The page revision is updated to v3.6.0, replacing the previous version.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, and the previous v3.5.4 entry was removed. This update represents an administrative adjustment to the study's revision history.SummaryDifference0.0%

- Check85 days agoChange DetectedA new site revision entry, Revision: v3.5.4, was added to the history, superseding the previous Revision: v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.